In a major relief to AstraZeneca, the Delhi High Court has granted summary judgment, confirming that Westcoast Pharmaceutical ...

Projected to be worth over $38 billion in the global healthcare market by 2032, AI simulations have the potential to ...

Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...

We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...

Current global health developments include China's green light for foreign-owned hospitals, the addition of AstraZeneca's ...

Friday, November 29, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Chevron ...

The U.S. pharmaceutical industry seeks to alter Medicare drug price negotiation laws under Trump's return. China approves ...

We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

A new study, supported by AstraZeneca, has shown that a single dose of benralizumab significantly reduces treatment failure ...

AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...

More telling than the revenue growth is IonQ's strategic positioning. The company secured a $54.5 million contract with the U ...